Sanofi

MENQUADFI

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Sanofi

Menquadfi HCPCS:

90619

HCPCS Code Descriptor:

Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier (MenACWY-TT), for intramuscular use

Category:

CPT Drug Code

Menquadfi NDCs:

49281-0590-05, 49281-0590-58, 49281-0590-10

Primary Type:

Vaccine-Meningococcal

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intramuscular

Menquadfi CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

49281-0590-10, 49281-0590-58, 49281-0590-05

About Menquadfi:

MENQUADFI is a Vaccine-Meningococcal drug manufactured by Sanofi and administered via the Intramuscular route of administration. The CPT Drug Code: 90619 is aligned to the drug MENQUADFI.

ACCESS PRICING AND MORE BY REGISTERING

90619 Added Date:

NA

90619 Effective Date:

NA

90619 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Menquadfi billing and coding information.
Menquadfi patient assistance information can be found through Sanofi Patient Connection at the URL: http://www.sanofipatientconnection.com/
MENQUADFI prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for MENQUADFI. Please check back in a few weeks.